Skip to main content
. 2016 Feb 11;11(2):e0148747. doi: 10.1371/journal.pone.0148747

Table 2. Clot lysis times (seconds) from thromboelastography and turbidimetry.

Value Healthy Control (Spec) Diabetes Mellitus (Spec) Obese Metabolic Syndrome (Spec) TOPCOAT (Spec) Total Sample (Spec) Healthy Control (TEG) Diabetes Mellitus (TEG) Obese Metabolic Syndrome (TEG) TOPCOAT (TEG) Total Sample (TEG)
Valid data (N) 20 10 10 76 116 20 10 10 76 116
Mean 4,898 7,243* 11,296* 5,014 5,369 4,741 10,529* 11,296* 7,319* 7,494
SD 920 1,907 4,914 1,657 1,770 1,029 4,561 4,914 4,735 4,659
Upper quartile 5,319 9,303 8,465 6,284 6,574 5,440 15,145 15,145 12,449 12,449
Median 4,685 7,308 7,235 4,628 5,018 4,703 11,225 14,925 5,095 5,363
Lower quartile 4,441 5,364 6,088 3,739 4,085 3,842 5,728 6,039 3,780 4,081
Centile 95 7,145 9,280 9,935 8,344 9,181 6,869 15,145 15,145 15,145 15,145
Centile 10 3,465 4,830 3,765 2,735 2,957 3,013 4,595 4,285 2,613 2,633

*p < 0.05 from one-way ANOVA with Dunnett’s comparison with control

Abbreviations: Spec-spectrophotometry (turbidimetric method); TEG-Thromboelastography; TOPCOAT-tenecteplase or placebo: cardiopulmonary outcomes at three months; SD-Standard deviation.